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Abstract.  
      Development and optimisation of therapeutic applications using biological scaffolds composed of 
naturally occurring extracellular matrix (ECM) have received significant attention in the field of tissue 
engineering. Histological and molecular investigations combined with comprehensive electron 
microscopy have shown that decellularised matrices from animal sources may vary in structure and 
biochemical properties. The source (bladder or small intestine submucosa), species, age of animal, and 
type of preparation of these matrices may contribute to the unique biophysical properties of the delivered 
product. Comparison of the thickness, topography, porosity and biomechanical properties of these 
matrices are presented. Vascular cell adhesion, migration and proliferation, and cell ingrowths on 
scaffold matrices were analysed using fluorescent labelling and laser confocal microscopy. ECM is 
shown to be a promising material for vascular tissue engineering and supports the growth, proliferation, 
anchoring and migration of human vasculature derived cells. Scaffold features tightly control the rate of 
adhesion and initiation of the proliferation. UBM scaffold containing an intact basal membrane may 
strongly influence the phenotype of the smooth muscle cells and control their proliferation-differentiation 
mechanisms. Data obtained will help realise and guide the research community with regard to the 
appropriate use of extracellular matrices derived from various animal organs based on their properties 
and suggests the possibility of conditioning this matrixes in order to influence their tissue and cell 
specificity before utilisation in clinical use. 
INTRODUCTION 
Tissue-engineering experiences over the last decade are shown that one of the keys component of the 
development of the functionally is the choice of 3-D scaffold with which tissue growth is guided [1]. 
Major characteristics of the scaffold not only accommodate and guide cell growth in the three-
dimensional space. A structural features such as the orientation of these fibers, affinity of the chemical 
groups on the surface of the scaffold have to support the attachment of the cells by the certain type of the 
integrins which will stimulate a correct proliferation rate of the cell, allow healthy mechano-transduction 
pathway mechanisms under the physiological flow and do not trigger production of a pro-inflammatory 
signaling molecules [2,3,4]. The list of 3D -scaffold materials continues to grow with development of 
new polymeric compounds and fabrication techniques [2]. Naturally derived materials offer many 
mechanical, chemical and biological advantages over synthetic materials, and thus hold tremendous 
potential for use in tissue engineering therapies. Tissue-engineering approaches utilizing the 
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decellularisation of the animal organs in order to obtain an advanced 3D- scaffold (decellularised 
Extracellular matrices –ECM) may serve as potential alternatives for synthetic polymeric materials in 
vascular medicine. This techniques are has typically required chemical or physical pretreatment aimed to 
preserve the tissue, enhance the resistance of the material to enzymatic degradation, and reduce the 
immunogenicity of the material. The distribution of natural polymers, their ratio, cross–linking pattern, 
elasticity, presence of the growth factors, total chemical composition and structure of the extracellular 
matrix are influenced by biomechanics and physiological function of the different source organ, and 
allow organ to function in an efficient manner and perform its unique organ function [6]. Limited number 
studies conducted biochemicals tests have been analyze the composition of decellularised matrices. 
Several authors applied histological tools to show 2 D- distribution of the structural component within the 
matrices, but are mostly limited by elastin and collagen content which are known to be the major content 
of the ECM matrix [7,8]. A lack of information and understanding of the spatial and dimensional 
distribution of different matrix components such as porosity and fibres thickness within the variety of the 
matrices led us to focus the current research on the detailed characterization the topographical features 
and structure of the polymer in 3D- distribution of natural component in the of the intracellular matrices 
derived from sub-intestinal submucosa (SIS) [6, 7] and urinary bladder matrix (UBM) [8]. These matrices 
have been successfully commercially applied in the regenerative medicine of the epidermis and skin. But 
in order to apply this scaffolds application of this in the challenging cardiovascular area, where potential 
failure of the graft may lead to sever problems even death, more data needs to be obtained to characterize 
this type of the material: their potential, their limitation and potential biological effect on the cells, which 
may be in contact with the scaffold. Recently, a few in vivo studies demonstrated an inconsistent 
performance of this material and the publications did not containing sufficient data on the complications. 
Source of the possible complication may only be hypothesized as follows:(a) diameter and anatomy of 
the vessels where material are introduced have been shown to have a defining role in the rate of the 
successful integration of the graft into the host tissue;(b) blood –compatibility and thrombogenisity of 
this material are not evaluated and understood;(c) certain ratio of the early calcification  of the 
decellularised tissue need to be investigated; (d) the performance of the various decellularised matrices 
correlate to multiplicity of the application and tissue–specific response in different organ replacement 
therapies. A possibility that the origin of the ECM, achievable biomechanical properties, structural 
components, variability between samples derived from animal to animal, age and gender, deposition of 
the structural component and growth factor are important and influencing factors and reflects on outcome 
of their clinical performance. The data or comparative assessment of the different material was not 
verified by other workers. The objective of this study was to inspect the mechanical and biological 
characteristics and provide an comparative data of the main features of two decellularised matrices 
extracted from small intestine submucosa (SIS) and Urinary Bladder Matrix (UBM). 
2. MATERIAL AND METHODS  
2.1 Origin of extracellular matrices  
The preparations of Urinary Bladder Matrix (UBM) and Small Intestinal Submucosa (SIS) have been 
previously described [6,7,8].  
2.2. Scanning electron microscopy 
     The surface morphology of the scaffolds and cell morphology post in vitro cell seeding study was 
examined using scanning electron microscopy (SEM). The specimens were washed with PBS three times, 
than fixed in 2.5% glutaraldehyde at 4oC and rinsed in PBS. All samples were post-fixed with 1% OsO4 
for 1 h followed by a dehydration process through a graded series of ethanol (30–100%, 10 min) and air 
dried in a fume hood. Gold spluttered samples were examined using a scanning electron microscope 
(SEM) at 5kV. 
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 2.3 GAG content determination - Alcian Blue staining 
 The amount of glycosaminoglycans (GAGs) in the decellularised matrices was determined using the 
Alcian Blue staining assay [9]. The presence and distribution of GAG groups was qualitatively verified 
by the accumulation of blue stain using an optical microscope. 
2.4. Biomechanical properties of the scaffolds 
    The ECM scaffolds of interest were cut into dog-bone shape specimens using a stainless steel template 
with dimensions as previously recommended [8]. Fibre direction and alignment were determined by a 
laser scanning confocal microscope (LSCM) system equipped with spectral detection system Meta 710 
(Carl Ziess). Figure 1 illustrates the sample preparation and test set-up.  
 
 
 
 
 
 
 
 
 
 
Fig.1 (a) Schematic representation of the sample preparation from decellularised material for 
biomechanical testing and (b) in situ experimental apparatus  
 
Samples were cut in the horizontal and longitudinal direction based on the fibre alignment determined for 
each sample analysed in this study. Specimens were immersed in PBS and allowed to hydrate for a short 
controlled period of time. The specimens were mounted in a uniaxial mechanical tensile testing machine 
developed in house; between two coarse screw-tightened grips to prevent slippage and maintaining an 
initial gauge length of 43mm. Specimens were loaded at a constant rate of 40mm/min until failure. A 
personal computer was connected to the testing machine and data recorded at a rate of 10 data points per 
second. Force and elongation values were recorded for each specimen. The maximum load (Fmax), 
elongation-at-failure (emax) and maximum tangential stiffness (Kimax) were also obtained. The initial 
length (e0) was measured at a load of 0.01N. The tangential stiffness was calculated as follows: 
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Where i is a data index indicator, F is the recorded force, and e is the recorded elongation. The maximum 
tangential stiffness was taken as the maximum value of K i. 
2.5. Repopulation of decellularised matrices by vascular cells in vitro  
2.5.1. Cell lines and growth media  
       Human aortic smooth muscle cells (SMCs) and endothelial cells (ECs) (PromoCell, Germany) 
originated for a 25 year old male donor with no cardiovascular disease. Cell lines were maintained in 
SMC medium (PromoCell, Germany) (containing 10% FBS, 1% SMCGS supplement and 1% pen/strep 
solution, and EC growth medium-2 (EGM-2, Lonza) both supplemented with 10% FBS. All cell cultures 
were maintained in a humidified incubator at 37°C and 5% CO2. 
 
 
2.5.2. Adhesion, migration, spread and ingrowth of vascular cells into the scaffold material 
     SMCs and ECs were seeded onto the luminal and abluminal sides of the lyophilized UBM and SIS 2.5 
cm2 disks at a density of 2 × 105 cells/cm2 and 3 × 103 cells/cm2 respectively. After 6 hours in culture, 
non-adherent cells were aspirated off. The viability of the SMCs and ECs on the scaffold matrix were 
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examined by Live/Dead assay (Invitrogen) at various time intervals. Briefly, cell seeded scaffolds were 
washed with PBS, incubated in calcein-AM (staining live cells) and EthD-1 (staining dead cells) in PBS 
for 30 min at RT. The localisation of cells on the surface and degree of penetration of seeded cells into 
the scaffold were visualised using LSCM.  
 
2.6 Assessment of the maintenance of the of vascular cell phenotypes.  
     The total RNA was extracted and reverse-transcribed to produce cDNA. PCR reactions were 
performed with specific primers for vWF and PECAM-1, SM-α actin, Smoothelin SM-Myosin Heavy 
Chain (SM-MHC) [9]. Amplification products were separated with 1.5% agarose gel electrophoresis and 
visualised with EtBr. Sufficient elimination of the DNA from the sample was confirmed by PCR 
amplification of the RNA sample without reverse transcriptase reaction. 
3. RESULTS AND DISCUSSION 
3.1 Structural properties of the decellularised matrices used  
 Structural properties of the two ECM materials vary dramatically. UBM thickness ranged from 80-300 
nm and was 7-10 folds thicker than the SIS scaffold. Thickness of the SIS material was in the range of 
15-80 µm. Representative images of material cross-sections are presented in Figure 2. UBM showed the 
capacity to be easily compressed. 
 
 
 
 
 
 
 
 
                   Fig.2 SEM micrograph of the cross-sections of the decellullarised scaffolds  
 
Analysis of the topographical material features showed that UBM and SIS scaffolds have bimodal surface 
characteristics. This was more pronounced in UBM as shown in Figure 3. Morphology of the luminal and 
abluminal surfaces has distinctive features and different degrees of roughness, fibre content and 
alignment and possibly cell spread and accommodation capabilities. Decellularised UBM contains a 
Basal Membrane (BM) which is absent in the SIS. BM is shown to be an important structural constituent 
of a blood vessel. Modulation of its structure is responsible for maintaining cell phenotype, proliferation 
rate of the ECs and SMCs and pro-inflammatory response on the shear stress. This study showed that 
mechanical extraction of the muscular components of the bladder can cause damage to occur in multiple 
regions which are often distributed over the graft surface and may serve as a ‘nucleation site’ for 
thrombogenic response and platelet infiltration. The degree of porosity of the UBM material is shown to 
increase with distance from the luminal to the abluminal side (size 15-70 µm). 
3.2 GAG content  
Many different genetically distinct core proteins combine with various GAG chains to form 
macromolecules expressing specific features and perform numerous functions. They influence the 
mechanical properties of tissues, regulate collagen matrix organisation, form an anti-thrombogenic 
barrier in the vascular lumen, participate in cell-cell or cell-ECM interactions and bind growth factors 
and viruses [11, 12]. Figure 4 illustrates the GAG content in the decellularised scaffold. The intensity of 
the colour corresponds to the amount of GAG. Degree of the sulfated GAG, in the graft materials needs 
to be determined, such as lipid retention from the blood and may associate with increase thrombogenic 
response shown to correlate with this component 
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Fig.3. Composed gallery of the SEM micrographs obtained from luminal and 
abluminal surfaces of the decellullarised scaffolds (UBM and SIS). 
 
 
 
 
 
 
 
 
 
Fig.4. Variability in the GAG content of decellullarised scaffolds (Alcian Blue staining).  
3.3 Mechanical properties of the decellularised scaffolds 
 The uniaxial tensile test data of UBM and SIS is summarised in Figure 5. Architecture and alignment of 
scaffold fibre is shown to play a critical role in the mechanical properties of the ECM. This is shown by 
the higher strength and stiffness of SIS upon uniaxial tensile testing in the preferred longitudinal fibre 
direction when compared with a horizontal fibre alignment. A higher maximum force and stiffness was 
observed in SIS compared to UBM, however, UBM scaffold exhibited more elastic properties and higher 
elongation properties. This result may reflect the physiological mechanical functions of the organ from 
which the ECM is derived. UBM does not possess the mechanical strength of the tunica submucosa in 
SIS but has the ability to expand with applied stretch. The anisotropic characteristics of UBM and SIS 
needs to be elucidated and in conjunction with already obtained data, in order to formulate methods for 
the preparation of various scaffolds with different properties, to reconstruct a multilayered construct with 
desirable properties of porosity, structural constituents and excellent compliance. 
 3.4. Vascular cell phenotype maintenance, adherence and behaviour on the scaffold 
 
 This study assessed the influence of structural features on adhesion, proliferation and the growth 
dynamics of human aortic cells (ECs and SMCs). Cellular distribution and attachment to the matrix 
during in vitro static culture were determined. A 3D-reconstruction from 23 single images was obtained 
from various depths of the EC and SMC seeded scaffold. Visualisation and the pattern of cell 
repopulation were obtained at various times of the cell growth on the scaffold (Fig. 6 and 7). 
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Fig.5. Biomechanical properties of UBM and SIS and their variability in break force, stiffness and 
elongation. 
 
The spatially uniform distribution reflects porosity and surface charge of the scaffold. The luminal side of 
the UBM containing the BM shows excellent capacity to support the migration of ECs. However, the 
initiation of cell attachment was pronounced in the region that showed a high degree of porosity or 
exposure to a structural roughness. 
 
Adhesion (6 hours) Spread  (3 days)
Cell
DA
 
 
Fig.6. 3D–LSCM image of aortic ECs on luminal side of decellularised material (static condition); (a) – 
after 6 hours of adhesion, cell (shown in black) showed attachment to less dense packed scaffold (DA); 
(b) - the spread of ECs (shown in white) after 3 days of the growth on scaffold surface (grey) 
 
The UBM material was shown to contain 150µm2 areas with a certain degree of BM damage. 
Monitoring of the fluorescence signal derived from live and metabolically active SMCs (Live/Dead 
Viability staining), the initial adhesion of the cells within these regions and pores is clearly visible and 
probably initiated by the higher degree of irregularity, roughness and availability of more chemical and 
structural groups for SMC attachment (Fig. 7) as similarly shown for the ECs (Fig. 6). To overcome this 
potential irregularity, additional aspects of cell-matrix cultivation should be considered. Dynamic stress 
stimuli may be beneficial for inducing evenly structured construct 
. 
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Fig.7.Adhesion and ingrowths of the SMCinto the luminal and abluminal sides of the bimodal basement 
membrane containing decellularised material (UBM) (Cell (white), scaffold (grey), pore (black due to 
absence of fluorescent signal)). 
 
The possible effect of the bioactive compounds from decellularised matrices (growth factors) on the on 
the phenotype of the seeded cell was evaluated. The expression of Von Willebrand factor (vWF) and 
PECAM -1 by ECs (7 days on the scaffold material) confirmed phenotype maintenance on UBM and SIS 
scaffold (Fig. 8). 
 
 
 
 
 
 
 
 
 
 
 
Fig.8. Results of the RT-PCR analysis of expression of phenotypic markers by the ECs and SMCs upon 
growth and proliferation of the decellularised matrices 
 
SMCs shown to be express of the smoothelin, SM-MHC and SM-α actin on both constructs (Fig 8), with 
low level of the myosin transcript during the growth on the SIS matrix. This may support the suggestion 
that cells with prolonged incubation time may undergo the switch to synthetic phenotype and the time 
taken for this to occur is modulated by the properties of the scaffold utilised for the cell maintenance. The 
stimulation of the construct by various physiological and chemical factors (pulsative flow, EC 
metabolites, etc.) in order to maintain a balance between remodeling of the scaffold, synthesis of the 
ECM components and the growth of the new tissue are currently under investigation. 
4. CONCLUSION 
An enormous effort by multidisciplinary groups has been put into the development of tissue engineered 
blood vessel substitutes over the last number of years. Among the various approaches, decellularisation 
of the animal organ and tissues in order to produce a bioactive scaffold, has shown to be a promising 
application in other soft tissues and can be adopted for the generation of the cell-seeded scaffold to create 
a viable blood vessel analogue or provide a sufficient cell-deliveries system into the pathological vessel. 
This study has shown that decellularised matrices from the animal sources may vary greatly by its 
structural and biochemical properties. Animal species, age of the donor organ and type of preparation of 
these matrices may contribute to the unique biophysical properties of the delivered product. The 
biomechanical properties of the scaffolds are shown to be influenced and probably correlate to the 
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biomechanics of the original organ from which the ECM material had been extracted. In relation to 
vascular tissue engineering, ECM is shown to support growth, proliferation, anchoring and migration of 
EC and SMC cell types obtained from human vasculature. Scaffold features tightly control the rate and 
initiation of adhesion, proliferation and migration. An intact basal membrane in the UBM strongly 
influences the phenotype of the smooth muscle cell and controls their proliferation-differentiation switch. 
Data obtained in this study will highlight the presence of these differences between various ECM 
materials and guide the research community to the appropriate use of available or newly produced 
extracellular matrices derived from various animal organs. Based on the data presented the ability of 
these materials to support attachment and growth of human vascular cells and sufficiently maintain their 
phenotype, the use of in vitro bioreactors for the conditioning of these matrices in order to influence their 
tissue and cell specificity [13] and remove traces of animal pro-immunogenic constituents by remodeling 
with human vascular cells before utilisation in clinical use all  need to be considered for further study. 
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